000636 风华高科
2026/06 - 中期
人民幣(K¥)
与去年同期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
营业总收入3,499,79726.28%5,756,4084,939,2464,221,4303,873,932
减:营业总成本3,194,33323.98%5,404,2664,565,7764,084,0023,663,358
    其中:营业成本2,843,33825.03%4,734,7713,992,2113,616,3543,177,849
               财务费用(19,166)-10.34%(51,477)(90,905)(138,494)(128,310)
               资产减值损失(41,320)-18.53%(152,574)(73,123)(32,450)(137,518)
公允价值变动收益--------974179
投资收益31,026127.70%42,25258,12748,978132,590
    其中:对联营企业和合营企业的投资收益21,819168.11%27,64143,42829,66356,242
营业利润316,96373.55%309,139390,010207,451327,652
利润总额318,14579.15%310,209368,147183,185347,388
减:所得税费用26,179160.25%24,86737,1991,9997,735
净利润291,96774.28%285,342330,947181,186339,653
减:非控股权益1,666137.76%2,025(6,421)7,70712,415
股东净利润290,30074.01%283,317337,369173,479327,237

市场价值指针
每股收益 (元) *0.25066.67%0.2500.2900.1500.310
每股派息 (元) *----0.1000.1500.0500.214
每股净资产 (元) *10.9362.67%10.81310.56410.31510.258
审计意见 #--标准的无保留意见标准的无保留意见标准的无保留意见标准的无保留意见
回页顶
备注: *未调整数据
#只提供简体内容